Table 2.
Comparison of the inhibition halos among different samples (Tukey's test at 5% probability).
Samples | Diameter of the inhibition halos (mm) ± SEM, n = 3 |
||
---|---|---|---|
E. coli | S. aureus | ||
GBP | GBP-1 | 11.1 ± 0.1a | 11.5 ± 0.1a |
GBP-2 | 11.1 ± 0.1a | 11.4 ± 0.1a | |
GBP-3 | 11.0 ± 0.1a | 11.4 ± 0.1a | |
GBP-4 | 10.5 ± 0.1b | 10.7 ± 0.1b | |
| |||
1 | A(a) | 13.9 ± 0.1a | 22.7 ± 0.1a |
A+GBP-1 | 13.4 ± 0.1b | 26.7 ± 0.1b(b) | |
A+GBP-2 | 13.0 ± 0.1c | 26.0 ± 0.1c(b) | |
A+GBP-3 | 13.0 ± 0.1c | 25.6 ± 0.1d(b) | |
A+GBP-4 | 13.1 ± 0.1c | 22.9 ± 0.1a | |
| |||
2 | C(a) | 18.2 ± 0.1a | 25.6 ± 0.1a |
C+GBP-1 | 22.8 ± 0.1 b(b) | 28.8 ± 0.1b(b) | |
C+GBP-2 | 22.2 ± 0.1c(b) | 28.1 ± 0.1c(b) | |
C+GBP-3 | 21.5 ± 0.1d(b) | 27.5 ± 0.1d(b) | |
C+GBP-4 | 18.2 ± 0.1a | 25.7 ± 0.1a | |
| |||
3 | G(a) | 26.3 ± 0.1a | 18.3 ± 0.1a |
G+GBP-1 | 29.6 ± 0.1b(b) | 25.8 ± 0.1b(b) | |
G+GBP-2 | 29.0 ± 0.1c(b) | 24.9 ± 0.1c(b) | |
G+GBP-3 | 28.5 ± 0.1d(b) | 24.4 ± 0.1d(b) | |
G+GBP-4 | 26.2 ± 0.1a | 18.4 ± 0.1a | |
| |||
4 | E(a) | / | 26.8 ± 0.1a |
E+GBP-1 | 11.6 ± 0.1b(b) | 29.5 ± 0.1b(b) | |
E+GBP-2 | 10.9 ± 0.1c(b) | 28.7 ± 0.1c(b) | |
E+GBP-3 | 10.5 ± 0.1d(b) | 28.2 ± 0.1d(b) | |
E+GBP-4 | 9.0 ± 0.1a | 26.3 ± 0.1a | |
| |||
5 | P(a) | 34.5 ± 0.1a | / |
P+GBP-1 | 33.9 ± 0.1b | 13.5 ± 0.1b(b) | |
P+GBP-2 | 34.0 ± 0.1b | 13.1 ± 0.1c(b) | |
P+GBP-3 | 34.1 ± 0.1b | 12.5 ± 0.1d(b) | |
P+GBP-4 | 33.9 ± 0.1b | 10.0 ± 0.1a |
(a)A: ampicillin, C: ciprofloxacin, G: gentamicin sulfate, E: erythromycin, and P: polymyxin B sulfate.
(b)Greater and having statistical difference compared with the corresponding antibiotics group (Tukey's HSD test, p < 0.05). The same lowercase letters (a, b, c, and d) in the column of the same group indicate no statistical difference (Tukey's HSD test, p > 0.05).